Glycolate oxidase is a safe and efficient target for substrate reduction therapy in a mouse model of primary hyperoxaluria Type I

  1. Martin-Higueras, C.
  2. Luis-Lima, S.
  3. Salido, E.
Revue:
Molecular Therapy

ISSN: 1525-0024,  1525-0016

Année de publication: 2016

Volumen: 24

Número: 4

Pages: 719-725

Type: Article

DOI: 10.1038/MT.2015.224 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus